Preconceptional Sex Selection Techniques — CPB 0323 | AETNA Coverage Update

TL;DR: Aetna, a CVS Health company, modified CPB 0323 governing preconceptional sex selection techniques, effective September 26, 2025. Here's what billing teams need to know before submitting claims against CPT codes 58321, 58322, 89261, or any of the S4011–S4042 IVF series.

Aetna's CPB 0323 Aetna sex selection coverage policy draws a hard line: sperm enrichment for X spermatozoa clears medical necessity only when preventing the conception of a male child in a woman who is a confirmed heterozygous carrier of a seriously handicapping X-linked condition—Lesch-Nyhan disease is the named example. Every other sex selection indication, including IVF (CPT codes in the S4011–S4042 range) and ICSI billed alongside flow cytometry codes 88182–88189, falls outside covered treatment. If your reproductive endocrinology or genetics practice bills Aetna, this update directly shapes how you document and route claims.

Quick-Reference Table

Aetna Preconceptional Sex Selection Coverage Criteria and Medical Necessity Requirements 2025

The Aetna preconceptional sex selection coverage policy is narrow. Aetna covers sperm enrichment for X spermatozoa under exactly one circumstance: the patient is a confirmed carrier of a seriously handicapping X-linked genetic condition, and the clinical goal is to prevent the birth of an affected male child.

That is the entire covered indication. The medical necessity bar is genetic documentation—heterozygous carrier status, confirmed through genetic testing, linked to a condition serious enough to meet Aetna's threshold. Lesch-Nyhan disease is the example Aetna names in CPB 0323, but the policy language extends to comparable conditions. Your documentation needs to name the specific X-linked condition and confirm carrier status. A referral from a genetics counselor (CPT 96040 or HCPCS S0265) supporting that determination strengthens the record.

For the sperm processing itself, CPT 89261 (complex sperm prep, e.g., Percoll or albumin gradient) is the central code when isolation is performed for enrichment. Flow cytometry codes—88182, 88184, 88185 (add-on), 88187, 88188, and 88189—come into play when sorting or analysis is part of the enrichment process. These codes get covered only when the underlying indication is the documented X-linked carrier scenario. Bill them outside that context and you are looking at a claim denial.

Prior authorization requirements for reproductive procedures vary by Aetna plan. The CPB itself does not specify a universal prior auth requirement, but given the narrow covered indication and the high claim value attached to IVF-adjacent procedures, confirm prior authorization requirements with the specific member's plan before you schedule. Do not assume silence on prior auth means the claim will flow through cleanly.

Aetna Preconceptional Sex Selection Exclusions and Non-Covered Indications

The exclusion in CPB 0323 is explicit and unambiguous. Assisted reproductive techniques—including IVF (HCPCS S4011–S4042) and ICSI—are not covered when the sole indication is sex selection without a serious X-linked genetic defect driving the request.

This matters because patients and providers sometimes assume reproductive procedures tied to family planning goals are covered under fertility benefits. They are not here. Aetna treats sex selection outside the X-linked carrier scenario as elective, not as treatment of disease. That framing is what drives the non-coverage determination.

Flow cytometry codes 88182–88189 and sperm analysis codes 89300, 89310, 89320, and 89321 follow the same logic. If the purpose is sex selection without the covered genetic indication, these services are not reimbursable under CPB 0323. Billing them against an IVF claim where the only driver is patient preference for sex will not survive a payer audit.

Embryo transfer (CPT 58974) and gamete or zygote intrafallopian transfer (CPT 58976) fall into the same category. Artificial insemination—intra-cervical (58321) or intra-uterine (58322)—can be part of the covered pathway when properly documented, but only when it serves the X-linked prevention goal. Outside that context, these are excluded under this coverage policy.

The real exposure here is mixed claims. A practice billing reproductive services across multiple indications may inadvertently bundle a sex-selection component with a separately covered fertility service. Auditors see that. Separate your billing paths clearly.

Coverage Indications at a Glance

Aetna Preconceptional Sex Selection Billing Guidelines and Action Items 2025

The effective date is September 26, 2025. If your team is billing any of these codes against Aetna plans today, these steps apply now.

CPT, HCPCS, and ICD-10 Codes for Preconceptional Sex Selection Under CPB 0323

CPT Codes Related to CPB 0323

HCPCS Codes Related to CPB 0323

Note on ICD-10 codes: CPB 0323 does not list specific ICD-10-CM codes in the policy data. Work with your coding team to identify the precise diagnosis codes for the patient's confirmed X-linked condition. The specificity of that diagnosis code is your primary medical necessity anchor on these claims.